I am 55 with BC and a family history. What testing helps?

Question

Hello doctor,

I am a 55-year-old woman with a history of breast cancer. Two years ago, I was diagnosed with invasive ductal carcinoma and underwent lumpectomy followed by chemotherapy and radiotherapy. My recent scans show no signs of recurrence, but I want to understand my genetic risk and explore whether cancer genome testing could guide future treatment or prevention.

I have a strong family history- my mother had breast cancer, and my maternal aunt had ovarian cancer.

I would like to know more about tests such as BRCA1 (Breast Cancer gene 1) and BRCA2 (Breast Cancer gene 2) mutation analysis, multi-gene panels, and tumor genomic profiling - how accurate they are, what they reveal, and how they might influence treatment options or surveillance?
I am also concerned about privacy, insurance implications, and how to interpret the results correctly. Could these tests help identify targeted therapies or help prevent recurrence?
Should my family members consider genetic counseling or testing as well?

Please help.

Thank you.

Answer 1

Hello,

Welcome to icliniq.com.

I have read your query and can understand your concern.

I completely understand how stressful it can feel thinking about genetics and future cancer risks, especially after going through breast cancer yourself. It is a lot to carry, and you are taking the right steps by asking these questions.

Causes:

Based on your personal history and strong family background, with your mother with breast cancer and your aunt with ovarian cancer, there is a likely hereditary cancer risk.
Most commonly, this involves BRCA1 (Breast Cancer gene 1) and BRCA2 (Breast Cancer gene 2) mutations, but other genes like PALB2 (Partner And Localizer of BRCA2), CHEK2 (Checkpoint kinase 2), ATM (ataxia-telangiectasia mutated), or TP53 can also contribute.
A mutation increases the risk of future breast or ovarian cancers and may influence preventive strategies for both you and close family members.

Diagnosis:

Genetic testing is the main tool to assess hereditary risk:

BRCA1 and BRCA2 germline testing: First-line testing for hereditary breast and ovarian cancer.
Expanded multi-gene panel: May include PALB2, CHEK2, ATM, TP53, and others; advised based on family and personal history.
Tumor genomic profiling: Focuses on the cancer cells themselves, mainly for treatment planning if cancer recurs.
Genetic counseling: Recommended before and after testing to explain results, implications, and family testing options.

Treatment plan:

If a mutation is detected:

Enhanced surveillance and screening schedules.
Risk-reducing measures, such as preventive surgery or chemoprevention.
Discussion of targeted treatments like PARP inhibitors if cancer recurs.
Family member testing and counseling.

If no mutation is detected:

Continue routine follow-up and standard screening.
Understand that risk is lowered but not eliminated.
Uncertain results: Require expert interpretation and follow-up.

Follow-Up:

Genetic counseling sessions to review results and implications.
Regular oncology follow-up to monitor overall health and recurrence.
Family testing and counseling if a hereditary mutation is identified.

Preventive Measures:

Maintain a healthy lifestyle (balanced diet, exercise, and maintaining a healthy weight).
Avoid smoking and limit alcohol intake.
Follow recommended cancer screening guidelines.
Discuss preventive strategies and options if a mutation is found.

You are taking a proactive, thoughtful step by exploring these options. Genetic counseling can provide clarity, guidance, and support for both your future care and your family’s health.

I hope this answers your query.

Please let me know if I can assist you further.

Thank you.